Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: allopurinol

« Back to Dashboard

Allopurinol is the generic ingredient in five branded drugs marketed by Accord Hlthcare, Apotex Inc, Ipca Labs Ltd, Mutual Pharm, Mylan, Northstar Hlthcare, Puracap Pharm, Purepac Pharm, Sandoz, Sun Pharm Inds Inc, Superpharm, Vintage Pharms, Watson Labs, Abbott, Dr Reddys La, Prometheus Labs, Eurohlth Intl, and Mylan Institutional, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for allopurinol. Nine suppliers are listed for this compound.

Summary for Generic Name: allopurinol

Tradenames:5
Patents:0
Applicants:18
NDAs:29
Drug Master File Entries: see list21
Suppliers: see list9
Therapeutic Class:Antigout Agents

Pharmacology for Ingredient: allopurinol

Clinical Trials for: allopurinol

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
Status: Recruiting Condition: Acute Lymphoblastic Leukemia (ALL)

Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
Status: Enrolling by invitation Condition: End Stage Renal Disease; Left Ventricular Hypertrophy

Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?
Status: Recruiting Condition: Hypertension; Hypertrophy, Left Ventricular

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
Status: Completed Condition: Mania

The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
Status: Terminated Condition: Blood Pressure; Gout

Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
Status: Completed Condition: Gout; Hyperuricemia

Allopurinol in Acute Coronary Syndrome
Status: Recruiting Condition: Chronic Stable Angina

Allopurinol Outcome Study
Status: Completed Condition: Gout

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
Status: Completed Condition: Schizophrenia; Schizoaffective Disorder

Allopurinol Combination Study
Status: Active, not recruiting Condition: Gout

Allopurinol in Acute Gout
Status: Withdrawn Condition: Gout

Antenatal Allopurinol During Fetal Hypoxia
Status: Active, not recruiting Condition: Fetal Hypoxia; Reperfusion Injury

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome
Status: Completed Condition: Hand-foot Syndrome

A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
Status: Terminated Condition: Diabetic Nephropathies

Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
Status: Completed Condition: Hyperuricosuria; Kidney Stones

A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
Status: Recruiting Condition: Diabetic Nephropathies; Coronary Artery Disease

Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Status: Recruiting Condition: Cardiovascular Disease

Does Allopurinol Prolong a Treated, Acute Gout Flare?
Status: Completed Condition: Gout

Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
Status: Completed Condition: Gout; Gout Acute

Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength'
Status: Enrolling by invitation Condition: Sarcopenia

Allopurinol Maintenance Study for Bipolar Disorder
Status: Completed Condition: Bipolar Disorder; Mania; Mixed Mania

Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized.
Status: Recruiting Condition: Patients With Grade II Ankle Sprain

Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients
Status: Completed Condition: Inflammatory Bowel Disease

Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
Status: Completed Condition: Gout

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Status: Completed Condition: Gout

Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Status: Completed Condition: Moderate to Severe Gout; Hyperuricemia

Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
Status: Recruiting Condition: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; de Novo Myelodysplastic Syndromes; Noncontiguous Stage II Adult Burkitt Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Stage I Adult Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage IV Adult Burkitt Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia

APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X
Status: Completed Condition: Syndrome X

Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
Status: Completed Condition: Fasting State

Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
Status: Completed Condition: Gout

A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient
Status: Recruiting Condition: Chronic Kidney Disease

Allopurinol Add-on Treatment for Refractory Mania
Status: Completed Condition: Bipolar Disorder; Mixed Mania; Treatment-Resistant Mania

RDEA3170 and Allopurinol Combination Study in Gout Subjects
Status: Not yet recruiting Condition: Gout

Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
Status: Withdrawn Condition: Cardiovascular Diseases; Cardiomyopathy, Dilated; Heart Diseases; Heart Failure, Congestive

Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol
Status: Completed Condition: Gout; Hyperuricemia; Arthritis; Joint Disease

The Effect of Allopurinol on Insulin Resistance and Blood Pressure
Status: Completed Condition: Metabolic Syndrome

Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
Status: Completed Condition: Gout

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
Status: Completed Condition: Gout

Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Status: Completed Condition: Leishmaniasis, Cutaneous

Antenatal Allopurinol in Intrauterine Growth Restriction
Status: Not yet recruiting Condition: Fetal Growth Retardation

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
Status: Completed Condition: Gout; Hyperuricemia; Arthritis; Joint Disease; Renal Insufficiency

Efficacy of Allopurinol and Dypiridamole in Acute Mania
Status: Completed Condition: Mania

Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease
Status: Completed Condition: Peripheral Arterial Disease

Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
Status: Completed Condition: Tumor Lysis Syndrome

Efficacy and Safety of Oral Febuxostat in Participants With Gout
Status: Completed Condition: Gout

Prednisone for Heart Failure Patients With Hyperuricemia
Status: Completed Condition: Heart Failure; Hyperuricemia

Allopurinol in Chronic Heart Failure
Status: Completed Condition: Chronic Heart Failure; Hyperuricemia

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
Status: Completed Condition: Tumor Lysis Syndrome; Cancer; Hyperuricemia

Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Status: Completed Condition: Heart Failure; Elevated Serum Uric Acid

Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy
Status: Completed Condition: Gout

Intravenous Allopurinol in Heart Failure
Status: Recruiting Condition: Congestive Heart Failure

Allopurinol for Renal Transplant Associated Hypertension in Children
Status: Terminated Condition: Hypertension; Renal Transplant

Impact of Diabetes on Left Ventricular Remodeling
Status: Completed Condition: Diabetes

Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia
Status: Active, not recruiting Condition: Gout and Hyperuricemia

Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Status: Completed Condition: Leishmaniasis

Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients
Status: Completed Condition: Chronic Heart Failure

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients
Status: Active, not recruiting Condition: Gout

Safety and Efficacy of Oral Febuxostat in Subjects With Gout
Status: Completed Condition: Gout

Uric Acid and Hypertension in African Americans
Status: Completed Condition: Cardiovascular Diseases; Heart Diseases; Hypertension

Uric Acid in Essential Hypertension in Children
Status: Completed Condition: Essential Hypertension

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Status: Recruiting Condition: Leukemia; Lymphoma

Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
Status: Completed Condition: Kidney Disease; Left Ventricular Hypertrophy

The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
Status: Completed Condition: Hyperuricemia; Chronic Kidney Disease

A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
Status: Completed Condition: Gout

Lesinurad and Allopurinol Combination Extension Study in Gout
Status: Enrolling by invitation Condition: Gout

Combining Lesinurad With Allopurinol in Inadequate Responders
Status: Completed Condition: Gout

Combining Lesinurad With Allopurinol in Inadequate Responders
Status: Completed Condition: Gout

Effect of Allopurinol Treatment on Insulin Resistance
Status: Recruiting Condition: Hyperuricemia; Prediabetes; Insulin Resistance

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
Status: Completed Condition: Intercritical Gout

Study of Cardiovascular Disease and Obstructive Sleep Apnea
Status: Recruiting Condition: Severe Obstructive Sleep Apnea (Apnea Hypopnea Index > 30 Events/Hour); Hypertension

Uric Acid and the Endothelium is CKD
Status: Recruiting Condition: Kidney Disease

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
Status: Terminated Condition: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer

Prednisone for Heart Failure Patients With Hyperuricemia
Status: Recruiting Condition: Heart Failure, Hyperuricemia

UAB Center of Research Translation (CORT) Project 2: The Effects of Urate Lowing Therapy (ULT) in Inflammation, Endothelial Function, and Blood Pressure
Status: Recruiting Condition: Pre-hypertension; JNC 7 Stage I Hypertension

An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia
Status: Completed Condition: Schizophrenia

Xanthine Oxidase Inhibition in Renal Transplant Recipients
Status: Recruiting Condition: Complications of Renal Transplant

Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
Status: Completed Condition: Adult Acute Lymphocytic Leukemia; High-Grade Lymphoma

Busulfan and Cyclophosphamide Followed By ALLO BMT
Status: Recruiting Condition: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Status: Active, not recruiting Condition: Chronic Lymphocytic Leukemia

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Status: Completed Condition: IgA Nephropathy

Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Status: Recruiting Condition: Renal Function; Endothelial Function; Blood Pressure; Overweight; Obesity

Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack
Status: Not yet recruiting Condition: Ischaemic Stroke

T-Cell Depleted Double UCB for Refractory AML
Status: Recruiting Condition: Acute Myelogenous Leukemia; Refractory Acute Myelogenous Leukemia

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Status: Recruiting Condition: Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes

PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
Status: Completed Condition: Gout

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Status: Completed Condition: Intercritical Gout

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Status: Completed Condition: Lymphoma, Non-Hodgkin; HIV Infections

Vascular Pathophysiology in Obstructive Sleep Apnea
Status: Withdrawn Condition: Obstructive Sleep Apnea

Hyperuricemia on Hypertension and Metabolic Syndrome
Status: Completed Condition: Systolic and Diastolic Blood Pressure Levels; Uric Acid Levels; Metabolic Syndrome Parameters; Hepatic Enzymes

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Active, not recruiting Condition: Leukemia

Rasburicase (Fasturtec) Registration Trial
Status: Terminated Condition: Hyperuricemia

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Status: Completed Condition: Non-Hodgkin's Lymphoma; Cancer

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Terminated Condition: Gout

Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants Administration
Status: Recruiting Condition: Obstructive Sleep Apnea Syndrome

Phase III Trial of Febuxostat in Korea Gout Patients
Status: Completed Condition: Gout

An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Status: Completed Condition: Diabetic Autonomic Neuropathy

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
Status: Completed Condition: Leukemia; Acute Lymphoblastic Leukemia

Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Status: Completed Condition: Leukemia; Lymphoma

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Status: Completed Condition: Acute Undifferentiated Leukemia; B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; L1 Adult Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Adult Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Status: Active, not recruiting Condition: Leukemia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ALLOPURINOL
allopurinol
TABLET;ORAL018877Sep 28, 1984RXNo<disabled><disabled>
Watson Labs
ALLOPURINOL
allopurinol
TABLET;ORAL018241Nov 16, 1984DISCNNo<disabled><disabled>
Mutual Pharm
ALLOPURINOL
allopurinol
TABLET;ORAL070466Dec 24, 1985DISCNNo<disabled><disabled>
Ipca Labs Ltd
ALLOPURINOL
allopurinol
TABLET;ORAL090637Mar 16, 2011RXNo<disabled><disabled>
Watson Labs
ALLOPURINOL
allopurinol
TABLET;ORAL018785Sep 28, 1984DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc